Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma
Public ClinicalTrials.gov record NCT00096616. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Single Dose, Randomized, Double-blind Crossover Comparison of Combivent CFC MDI and Albuterol HFA MDI in Patients With Moderate to Severe Persistent Asthma and Persistent Symptoms Despite Treatment With Inhaled Corticosteroids
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to demonstrate the superior bronchodilator efficacy of inhaled Combivent® CFC MDI vs. Albuterol HFA MDI in moderate to severe asthma patients.
Study identification
- NCT ID
- NCT00096616
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 113 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2004
- Primary completion
- Feb 28, 2006
- Completion
- Not listed
- Last update posted
- Oct 31, 2013
Started 2004
United States locations
- U.S. sites
- 27
- U.S. states
- 19
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 620 South 20th Street, NHB 104 | Birmingham | Alabama | — | — |
| Cooper Green Hospital | Birmingham | Alabama | — | — |
| Southern California Clinical Trials | Lakewood | California | — | — |
| Boehringer Ingelheim Investigational Site | Palmdale | California | — | — |
| Boehringer Ingelheim Investigational Site | Wheat Ridge | Colorado | — | — |
| Norwalk Hospital | Norwalk | Connecticut | — | — |
| University of Miami School of Medicine | Miami | Florida | — | — |
| Boehringer Ingelheim Investigational Site | Panama City | Florida | — | — |
| Boehringer Ingelheim Investigational Site | Coeur d'Arlene | Idaho | — | — |
| Boehringer Ingelheim Investigational Site | River Forest | Illinois | — | — |
| Boehringer Ingelheim Investigational Site | Olathe | Kansas | — | — |
| LSU MC-Sheveport | Shreveport | Louisiana | — | — |
| Boehringer Ingelheim Investigational Site | Auburn | Maine | — | — |
| Johns Hopkins Asthma & Allergy | Baltimore | Maryland | — | — |
| Brigham & Women's Hospital | Boston | Massachusetts | — | — |
| Boehringer Ingelheim Investigational Site | Berlin | New Jersey | — | — |
| Boehringer Ingelheim Investigational Site | Cherry Hill | New Jersey | — | — |
| North Shore University Hospital | Manhasset | New York | — | — |
| NYU School of Medicine | New York | New York | — | — |
| Division of Pulmonary & Critical Care Medicine | Durham | North Carolina | — | — |
| Wake Forest University, Center for Human Genomics | Winston-Salem | North Carolina | — | — |
| Penn State University, Hershey Medical Center | Hershey | Pennsylvania | — | — |
| Boehringer Ingelheim Investigational Site | Charleston | South Carolina | — | — |
| Spartanburg Medical Research | Spartanburg | South Carolina | — | — |
| Ben Taul General Hospital | Houston | Texas | — | — |
| University of Texas Health Center at Tyler | Tyler | Texas | — | — |
| University of Wisconsin Hospital | Madison | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00096616, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 31, 2013 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00096616 live on ClinicalTrials.gov.